🏢 Company
Intellia Therapeutics
American biotechnology company
📊 Rating
1 news mentions · 👍 0 likes · 👎 0 dislikes
📌 Topics
- Biotechnology (1)
- FDA Regulation (1)
- Stock Market Analysis (1)
- Pharmaceutical Trials (1)
🏷️ Keywords
Intellia Therapeutics (1) · FDA Clinical Hold (1) · Stock Price Target (1) · ATTR-CM (1) · NASDAQ:NTLA (1) · Analyst Ratings (1) · Biotechnology Stocks (1) · Pharmaceutical Trials (1)
📖 Key Information
Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise editing of disease-causing genes directly within specific target tissues.
